Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Agilon Health (AGL) Non-Current Receivables (2021 - 2022)

Agilon Health (AGL) has disclosed Non-Current Receivables for 2 consecutive years, with $69.4 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Non-Current Receivables fell 9.44% year-over-year to $69.4 million, compared with a TTM value of $69.4 million through Dec 2022, down 9.44%, and an annual FY2022 reading of $69.4 million, down 9.44% over the prior year.
  • Non-Current Receivables was $69.4 million for Q4 2022 at Agilon Health, down from $76.6 million in the prior quarter.
  • Across five years, Non-Current Receivables topped out at $76.6 million in Q4 2021 and bottomed at $69.4 million in Q4 2022.